Nanoparticles provide several advantages in immunosuppressive therapies:
- Targeted Delivery: Enhances the concentration of the drug at the desired site while reducing systemic exposure. - Reduced Side Effects: Minimizes adverse reactions by preventing the drug from impacting non-target cells. - Enhanced Efficacy: Improves the therapeutic index of immunosuppressive drugs. - Controlled Release: Allows for sustained and controlled drug release, reducing the frequency of administration.
